持田製薬の業績推移
(単位:百万円)
|
売上高 |
営業利益 |
経常利益 |
純利益 |
売上原価 |
売上総利益 |
株主資本 |
総負債 |
総資産 |
現金及び現金同等物 |
流動市場性有価証券 |
流動資産 |
流動負債 |
利益剰余金 |
営業利益率 |
経常利益率 |
当期利益率 |
自己資本比率 |
営業キャッシュフロー |
投資キャッシュフロー |
財務キャッシュフロー |
営業キャッシュフローマージン |
フリーキャッシュフロー |
ROE |
ROA |
一株あたり利益 |
希薄化後一株あたり利益 |
従業員数 |
2024年3月
|
102,885
|
5,802
|
6,037
|
4,547
|
50,815
|
52,070
|
127,967
|
30,833
|
158,800
|
33,290
|
|
116,662
|
26,073
|
117,022
|
5.64%
|
5.87%
|
4.42%
|
80.58%
|
-7,480
|
74
|
-6,393
|
-7.27%
|
-7,406
|
3.57%
|
2.86%
|
0.0001268
|
0.0001268
|
1522人
|
2023年3月
|
103,261
|
8,507
|
9,085
|
6,649
|
48,146
|
55,115
|
126,775
|
32,056
|
158,831
|
47,010
|
|
117,379
|
27,258
|
118,943
|
8.24%
|
8.8%
|
6.44%
|
79.82%
|
7,297
|
-2,949
|
-6,884
|
7.07%
|
4,348
|
5.21%
|
4.13%
|
0.00017893
|
0.00017893
|
1529人
|
2022年3月
|
110,179
|
14,392
|
14,799
|
10,569
|
50,626
|
59,553
|
128,646
|
34,493
|
163,139
|
48,415
|
|
121,448
|
29,856
|
121,668
|
13.06%
|
13.43%
|
9.59%
|
78.86%
|
7,459
|
-2,007
|
-5,956
|
6.77%
|
5,452
|
8.27%
|
6.51%
|
0.00027739
|
0.00027739
|
1544人
|
2021年3月
|
102,995
|
12,003
|
12,260
|
8,587
|
48,203
|
54,792
|
126,974
|
34,817
|
161,791
|
54,487
|
|
118,793
|
28,710
|
116,288
|
11.65%
|
11.9%
|
8.34%
|
78.48%
|
9,198
|
-880
|
-5,112
|
8.93%
|
8,318
|
6.94%
|
5.38%
|
0.00022229
|
0.00022229
|
1558人
|
2020年3月
|
101,799
|
8,807
|
9,154
|
4,598
|
49,882
|
51,917
|
120,665
|
36,823
|
157,488
|
53,291
|
|
116,894
|
28,562
|
110,800
|
8.65%
|
8.99%
|
4.52%
|
76.62%
|
9,347
|
-1,760
|
-5,328
|
9.18%
|
7,587
|
3.74%
|
2.91%
|
0.00011756
|
0.00011756
|
1581人
|
2019年3月
|
109,643
|
10,590
|
10,928
|
8,435
|
55,477
|
54,166
|
125,110
|
33,909
|
159,019
|
51,032
|
|
115,334
|
28,444
|
109,537
|
9.66%
|
9.97%
|
7.69%
|
78.68%
|
12,565
|
-1,121
|
-6,094
|
11.46%
|
11,444
|
6.89%
|
5.37%
|
0.00021287
|
0.00021287
|
1617人
|
2018年3月
|
106,761
|
11,662
|
12,008
|
9,023
|
53,182
|
53,579
|
119,687
|
35,367
|
155,054
|
45,683
|
|
113,151
|
29,574
|
104,625
|
10.92%
|
11.25%
|
8.45%
|
77.19%
|
3,283
|
-426
|
-3,483
|
3.08%
|
2,857
|
7.79%
|
5.95%
|
0.00022727
|
0.00022727
|
1666人
|
2017年3月
|
97,349
|
11,374
|
11,648
|
8,526
|
41,043
|
56,306
|
111,869
|
36,503
|
148,372
|
46,308
|
|
112,016
|
30,269
|
100,040
|
11.68%
|
11.97%
|
8.76%
|
75.4%
|
5,583
|
-1,835
|
-3,291
|
5.74%
|
3,748
|
7.87%
|
5.96%
|
0.00021473
|
0.00021473
|
1713人
|
2016年3月
|
92,272
|
12,154
|
12,392
|
8,150
|
37,273
|
54,999
|
104,929
|
32,784
|
137,713
|
28,916
|
|
102,043
|
25,795
|
96,598
|
13.17%
|
13.43%
|
8.83%
|
76.19%
|
15,211
|
-15,576
|
-2,917
|
16.48%
|
-365
|
8.01%
|
6.14%
|
0.00020523
|
0.00020523
|
1726人
|
2015年3月
|
87,252
|
11,689
|
11,909
|
7,544
|
33,913
|
53,339
|
98,670
|
28,887
|
127,557
|
31,016
|
|
91,904
|
22,443
|
91,884
|
13.4%
|
13.65%
|
8.65%
|
77.35%
|
5,122
|
-1,953
|
-5,288
|
5.87%
|
3,169
|
7.84%
|
5.84%
|
0.00018863
|
0.00018863
|
1746人
|
2014年3月
|
93,947
|
16,600
|
16,799
|
9,892
|
34,364
|
59,583
|
93,688
|
36,981
|
130,669
|
33,135
|
|
93,842
|
29,041
|
90,762
|
17.67%
|
17.88%
|
10.53%
|
71.7%
|
12,478
|
-4,359
|
-6,089
|
13.28%
|
8,119
|
10.86%
|
7.87%
|
0.00048866
|
0.00048866
|
1726人
|
2013年3月
|
89,210
|
14,017
|
14,188
|
9,152
|
32,797
|
56,413
|
88,542
|
32,286
|
120,828
|
29,109
|
|
86,692
|
25,354
|
87,062
|
15.71%
|
15.9%
|
10.26%
|
73.28%
|
11,909
|
-1,964
|
-4,122
|
13.35%
|
9,945
|
10.72%
|
7.83%
|
0.00044226
|
0.00044226
|
1753人
|
2012年3月
|
86,205
|
|
15,286
|
9,076
|
|
|
82,189
|
30,682
|
112,871
|
27,900
|
|
|
|
|
0.0%
|
17.73%
|
10.53%
|
72.82%
|
8,706
|
-1,254
|
-6,395
|
10.1%
|
7,452
|
|
|
0.00043046
|
0.00043046
|
1730人
|
2011年3月
|
79,506
|
|
12,017
|
5,333
|
|
|
|
|
|
|
|
|
|
|
0.0%
|
15.11%
|
6.71%
|
|
|
|
|
|
|
|
|
0.00024222
|
0.00024222
|
1721人
|
2010年3月
|
79,460
|
|
14,921
|
9,869
|
|
|
|
|
|
|
|
|
|
|
0.0%
|
18.78%
|
12.42%
|
|
|
|
|
|
|
|
|
0.00043428
|
0.00043428
|
1727人
|